Literature DB >> 17634715

Prostate cancer with supraclavicular lymphadenopathy and bulky abdominal tumor.

Shigeki Kosugi1, Syoko Mizumachi, Akiko Kitajima, Takumi Igarashi, Takamasa Hamada, Hitoshi Kaya, Kazunao Kurihara, Koji Ogasawara, Hitomi Sakata, Masahiro Yamamoto, Mamoru Nagamine, Hiroyuki Yamazaki.   

Abstract

A 73-year-old man with suspected lymphoproliferative disorder was introduced to our hospital. The patient demonstrated palpable hard masses in the abdomen. Enhanced computed tomography of the abdomen and pelvis revealed a bulky mass of para-aortic lymph nodes. Biopsy of left-sided supraclavicular lymph nodes revealed metastatic adenocarcinoma. Serum tumor markers were examined, revealing prostate-specific antigen (PSA) levels of 3,354.0 ng/ml. Rectal examinations revealed a stony-hard prostatic mass. Biopsy of the prostate disclosed poorly to moderately differentiated adenocarcinoma. Although metastases to the supraclavicular lymph nodes are rare in prostate cancer, it should be distinguished from malignant lymphoma and other malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634715     DOI: 10.2169/internalmedicine.46.0014

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report.

Authors:  Liming Zhu; Cong Luo; Wei Wu; Jier Ying; Haijun Zhong
Journal:  J Res Med Sci       Date:  2013-09       Impact factor: 1.852

2.  Generalized lymphadenopathy: unusual presentation of prostate adenocarcinoma.

Authors:  Bulent Cetin; Zeynep Cetin; Suleyman Buyukberber; Ipek Isık Gonul; Ilgin Sahiner; Ugur Coskun; Mustafa Benekli
Journal:  Case Rep Urol       Date:  2011-08-23

3.  AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.

Authors:  Rashi Kalra; Ella Bhagyaraj; Drishti Tiwari; Ravikanth Nanduri; Anuja P Chacko; Monika Jain; Sahil Mahajan; Neeraj Khatri; Pawan Gupta
Journal:  Oncogenesis       Date:  2018-05-25       Impact factor: 7.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.